We conducted the first investigation of the underlying molecular mechanisms of DEPDC1 dysregulation on the malignant phenotype of liposarcoma cells, which provided new insight into exploring the pathogenesis ofliposarcoma. This evidence concerns the gene DEPDC1 and liposarcoma.